Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph M Meyer

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
European Journal of Haematology. Supplementum|July 13, 2005
Is there convincing evidence for the use of chemotherapy alone in patients with limited stage Hodgkin's lymphoma?Ralph M Meyer
Clinical Advances in Hematology & Oncology : H&O|April 20, 2013
Radiation in early-stage Hodgkin lymphomaRalph M Meyer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 26, 2009
Generalizing the results of cancer clinical trialsRalph M Meyer
Blood|May 4, 2013
EBV DNA: a Hodgkin lymphoma biomarker?Ralph M Meyer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 14, 2011
Evolution of clinical trials registriesRalph M Meyer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 19, 2013
Surrogacy of financial conflicts of interestRalph M Meyer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 4, 2017
Limited-Stage Hodgkin Lymphoma: Clarifying UncertaintyRalph M Meyer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2017
Reply to J.A. Vargo et al, H.J.A. Adams et al, E. Hindié et al, and S. Kothari et alRalph M Meyer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2014
Limited-stage hodgkin lymphoma: managing uncertaintyRalph M Meyer
Hematology. American Society of Hematology. Education Program|November 25, 2006
The management of patients with limited-stage classical Hodgkin lymphomaMary K Gospodarowicz, Ralph M Meyer
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
European Journal of Haematology. Supplementum|July 13, 2005
Is there convincing evidence for the use of chemotherapy alone in patients with limited stage Hodgkin's lymphoma?Ralph M Meyer
Clinical Advances in Hematology & Oncology : H&O|April 20, 2013
Radiation in early-stage Hodgkin lymphomaRalph M Meyer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 26, 2009
Generalizing the results of cancer clinical trialsRalph M Meyer
Blood|May 4, 2013
EBV DNA: a Hodgkin lymphoma biomarker?Ralph M Meyer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 14, 2011
Evolution of clinical trials registriesRalph M Meyer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 19, 2013
Surrogacy of financial conflicts of interestRalph M Meyer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 4, 2017
Limited-Stage Hodgkin Lymphoma: Clarifying UncertaintyRalph M Meyer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2017
Reply to J.A. Vargo et al, H.J.A. Adams et al, E. Hindié et al, and S. Kothari et alRalph M Meyer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2014
Limited-stage hodgkin lymphoma: managing uncertaintyRalph M Meyer
Hematology. American Society of Hematology. Education Program|November 25, 2006
The management of patients with limited-stage classical Hodgkin lymphomaMary K Gospodarowicz, Ralph M Meyer
Pageof 9